In this prospective multicenter double-blind placebo-controlled fixed-dose parallel-group phase III trial , 452 patients with diabetes ( type 1 or type 2 ) and ED were randomized to take 10 or 20 mg vardenafil or placebo as needed for 12 weeks .
